Anti-human DLL3 monoclonal antibody, rovalpituzumab biosimilar (SC0001-SCX, SC0002)

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1061-100ug

  • Size

    100 ug

  • Price

    $350

1
This monoclonal antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
target DLL3
alias SCDO1
gene id Uniprote ID: Q9NYJ7
host species Humanized
reactivity Human
iso type IgG1
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml, solubilize at RT for 30 minutes with occasional gentle tapping. It is recommended that 0.1% HSA be added as a carrier protein for long-term storage.
applications ELISA, Flow Cytometry
dilution ELISA 1:5000-10000, Flow Cyt 1:100
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.
note Other commonly used names in publications refering to this antibody: SC0001-SCX, SC0002, sc0001-SCX

Images

Flow cytometry analysis of anti-DLL3 (Rovalpituzumab biosimilar) mAb 15 ug/ml on Expi293 cells transfected with Human DLL3 (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).

ELISA plate coated with 2 ug/mL (100 uL/well) Human DLL3 Protein, hFc Tag binds to anti-DLL3 (Rovalpituzumab biosimilar) mAb in a linear range of 0.64?80 ng/mL.


PRODUCT

  • SKU

    DMS1061-100ug

  • Size

    100 ug

  • Price

    $350

1